Fig. 2From: Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and deliveryRelationship between the virulence of non-tuberculous mycobacteria species, treatment outcomes, and drug susceptibility [42]Back to article page